tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IN:LUPIN Stock Latest News

Lupin Says GST Department Inspection Concludes With No Financial Impact
Company AnnouncementsLupin Says GST Department Inspection Concludes With No Financial Impact
18h ago
LUPIN
Lupin Wins Positive U.S. FDA Inspection Outcome for Goa Plant
PremiumCompany Announcements
Lupin Wins Positive U.S. FDA Inspection Outcome for Goa Plant
4d ago
LUPIN
Lupin CEO Vinita Gupta Named CNBC Changemaker as U.S. Expansion Gains Momentum
PremiumCompany Announcements
Lupin CEO Vinita Gupta Named CNBC Changemaker as U.S. Expansion Gains Momentum
5d ago
LUPIN
Lupin Tops Global Pharma and India Rankings in S&P ESG Assessment 2025
PremiumCompany Announcements
Lupin Tops Global Pharma and India Rankings in S&P ESG Assessment 2025
5d ago
LUPIN
Lupin Partners with TB Alliance to Advance Telacebec for Tuberculosis and Other Mycobacterial Diseases
PremiumCompany Announcements
Lupin Partners with TB Alliance to Advance Telacebec for Tuberculosis and Other Mycobacterial Diseases
29d ago
LUPIN
Lupin Strikes Global Semaglutide Deal With Galenicum Across 23 Markets
PremiumCompany AnnouncementsLupin Strikes Global Semaglutide Deal With Galenicum Across 23 Markets
1M ago
LUPIN
Lupin and PolyPeptide Forge Alliance to Boost Global Peptide Supply Chain
Premium
Company Announcements
Lupin and PolyPeptide Forge Alliance to Boost Global Peptide Supply Chain
3M ago
LUPIN
Lupin Limited Gains U.S. FDA Approval for First Biosimilar, Armlupeg
Premium
Company Announcements
Lupin Limited Gains U.S. FDA Approval for First Biosimilar, Armlupeg
3M ago
LUPIN
Lupin Limited Faces FDA Inspection Observations at Goa Facility
PremiumCompany Announcements
Lupin Limited Faces FDA Inspection Observations at Goa Facility
3M ago
LUPIN
Lupin Launches First PrecisionSphere™ Product in U.S. with Risperidone Injectable
PremiumCompany Announcements
Lupin Launches First PrecisionSphere™ Product in U.S. with Risperidone Injectable
4M ago
LUPIN
Lupin Limited Receives U.S. FDA Approval for Aurangabad Facility
PremiumCompany Announcements
Lupin Limited Receives U.S. FDA Approval for Aurangabad Facility
4M ago
LUPIN
Lupin Bioresearch Center Achieves Zero Observations from U.S. FDA
PremiumCompany Announcements
Lupin Bioresearch Center Achieves Zero Observations from U.S. FDA
4M ago
LUPIN
Lupin Limited’s PEGASUS Study: A New Horizon in Pediatric Myotonic Disorder Treatment
PremiumCompany AnnouncementsLupin Limited’s PEGASUS Study: A New Horizon in Pediatric Myotonic Disorder Treatment
4M ago
LUPIN
Lupin Limited’s ACHILLES Study: A New Horizon in Myotonia Treatment
Premium
Company Announcements
Lupin Limited’s ACHILLES Study: A New Horizon in Myotonia Treatment
4M ago
LUPIN
Lupin Limited’s Phase 3 Study on Mexiletine PR: A Potential Game-Changer for Myotonic Dystrophy
Premium
Company Announcements
Lupin Limited’s Phase 3 Study on Mexiletine PR: A Potential Game-Changer for Myotonic Dystrophy
4M ago
LUPIN
Lupin Limited’s New Study on Mexiletine PR: A Potential Game-Changer for Myotonic Dystrophy Treatment
PremiumCompany Announcements
Lupin Limited’s New Study on Mexiletine PR: A Potential Game-Changer for Myotonic Dystrophy Treatment
4M ago
LUPIN
Lupin Limited Launches Generic Version of Ravicti® in U.S.
PremiumCompany Announcements
Lupin Limited Launches Generic Version of Ravicti® in U.S.
4M ago
LUPIN
Lupin Limited’s New Jersey Facility Undergoes FDA Inspection
PremiumCompany Announcements
Lupin Limited’s New Jersey Facility Undergoes FDA Inspection
5M ago
LUPIN
Lupin’s Pithampur Facility Receives OAI Classification from U.S. FDA
PremiumCompany Announcements
Lupin’s Pithampur Facility Receives OAI Classification from U.S. FDA
5M ago
LUPIN
Lupin Limited Expands European Presence with VISUfarma Acquisition
PremiumCompany AnnouncementsLupin Limited Expands European Presence with VISUfarma Acquisition
5M ago
LUPIN
Lupin Limited Announces Key Resolutions Passed via Postal Ballot
Premium
Company Announcements
Lupin Limited Announces Key Resolutions Passed via Postal Ballot
5M ago
LUPIN
Lupin Limited Gains U.S. FDA Approval for Lenalidomide Capsules
Premium
Company Announcements
Lupin Limited Gains U.S. FDA Approval for Lenalidomide Capsules
6M ago
LUPIN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >